FDA to Receive Additional Funding for FY 2009
Before Congress recessed in late September, the House and Senate took action to ensure an increase in FDA funding for fiscal year 2009. Under the Continuing Resolution, which was signed into law by the President on September 30, 2008, the Food and Drug Administration will be able to spend funds at a higher rate than it did in the current fiscal year. The increase contained in the Continuing Resolution is estimated at $150 million. Coupled with a $150 million FY 2008 reserve, the agency should see a budget increase in 2009 of $300 million.
More importantly, this step signals that Congress realizes the funding needs of the FDA. Even though 2009 will be tight budget year for all federal agencies as a result of the turbulent economy, the FDA can anticipate strong support from Congressional champions and plan appropriately. Because the fiscal strength of the FDA will prove crucial to enhancing the Agency’s ability to appropriately evaluate new treatments for Alzheimer’s disease, ACT-AD continues to be a strong advocate for this cause.
New Coalition Member
ACT-AD is pleased to welcome its newest member, the American Academy of Neurology (AAN). Established in 1948, the AAN is an international professional association of more than 21,000 neurologists and neuroscience professionals dedicated to providing the best possible care for patients with neurological disorders. They provide information on practice, education, research, and opportunities in the field of neurology.
AAN aims to create and shape the neurology curriculum in medical schools and provide continuing education resources for neurology professionals. Well trained neurologists and researchers are vital to treating and finding a cure for Alzheimer’s disease. As our fifty-third member, AAN will help strengthen the Coalition while adding to the breath and scope of ACT-AD’s outreach activities.
For more information on AAN, please visit their website- www.aan.com.